Search results
Oramed Pharmaceuticals' Oral COVID-19 Vaccine Candidate Shows Safety, Immunogenicity In Early Study
Benzinga via Yahoo Finance· 2 years agoOramed Pharmaceuticals Inc's (NASDAQ: ORMP) subsidiary, Oravax Medical Inc, reported preliminary...
FDA Panel Endorses Simplification of COVID-19 Vaccine Strategy
Zacks via Yahoo Finance· 1 year agoOn Jan 26, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC)...
Pfizer Expects $10-$15B From mRNA Vaccine Sales By 2030, Sees $17B Revenues Lost Due To Patent...
Benzinga via Yahoo Finance· 1 year agoAt Pipeline Day, Pfizer Inc (NYSE: PFE) forecasts annual revenue from its mRNA vaccine portfolio...
Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says
CNN via Yahoo News· 8 months agoin a Phase 1/2 clinical trial, Moderna’s combination vaccine appeared to elicit “strong” immune...
Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy
Politico via Yahoo News· 1 year agoThe FDA’s expert panel on vaccines voted Thursday to recommend that anyone who gets a primary Covid...
Pfizer (PFE) Starts EU Submission of Variant-Adapted Vaccine
Zacks via Yahoo Finance· 2 years agoPfizer PFE and its partner BioNTech BNTX announced that the European Medicines Agency (EMA)...
A Lyme Disease Vaccine Is in Late-Stage Clinical Trials—Here’s What You Need to Know
Prevention via Yahoo News· 2 years agoA Lyme disease vaccine has entered phase 3 clinical trials, per Pfizer. Here's how the vaccine...
PFE, BNTX and MRNA Omicron Boosters Get Positive CHMP Opinion
Zacks via Yahoo Finance· 2 years agoIt has been a good week for leading COVID-19 vaccine makers, Pfizer PFE /BioNTech BNTX and Moderna...
FDA: Pfizer, Moderna vaccines for kids under 6 are safe, effective
Politico via Yahoo News· 2 years agoThe FDA analyzed the vaccines' ability to induce neutralizing antibody responses in kids that were...
Merck's (MRK) Pneumococcal Jab Shows Upbeat Responses in Study
Zacks via Yahoo Finance· 6 months agoPositive data from Merck's (MRK) phase III study on V116, an investigational, 21-valent pneumococcal...